Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1156276 | 0.84 | — | — | |
| Hydrochloric Acid SCHEMBL534853 | 0.84 | — | — | |
| Iodide SCHEMBL670623 | 0.84 | — | — | |
| Hydrochloric Acid SCHEMBL30102493 | 0.82 | — | — | |
| SCHEMBL9923620 | 0.79 | TSHR (0.33) | — | |
| SCHEMBL2827554 | 0.79 | — | — | |
| Bicarbonate SCHEMBL29742345 | 0.79 | KDM4E (0.30) | — | |
| Hydrochloric Acid SCHEMBL9893439 | 0.78 | TSHR (0.32) | — | |
| SCHEMBL325542 | 0.76 | ALDH1A1 (0.31) | — | |
| Trifluoromethanesulfonic Acid SCHEMBL6483813 | 0.71 | GPR3 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9688641-B2 | Process for preparing asymmetrical imidazolium salts | ECOLE NATIONALE SUPERIEURE DE CHIMIE DE RENNES (FR) | 2017-06-27 | — | — | US | disclosed |
| US-9688641-B2 | Process for preparing asymmetrical imidazolium salts | ECOLE NATIONALE SUPERIEURE DE CHIMIE DE RENNES (FR) | 2017-06-27 | — | — | US | disclosed |
| US-20150329494-A1 | Process for Preparing Asymmetrical Imidazolium Salts | Ecole National Superieure de Chimie de Rennes (FR) | 2015-11-19 | — | — | US | disclosed |
| US-20150329494-A1 | Process for Preparing Asymmetrical Imidazolium Salts | Ecole National Superieure de Chimie de Rennes (FR) | 2015-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150329494-A1 | Process for Preparing Asymmetrical Imidazolium Salts | HRH4, F12, ADH1A | CYP3A4 134/4885CHRM1 79/4885ALOX15 1730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.